Menu

ACCESSIBILITY

The Site is brought to you by Sinclair Pharma Ltd (Sinclair). Our registered office is 30-32 Whitfield Street, Whitfield Court, London, W1T 2RQ with company registration number 03816616.

Sinclair recognises the importance of providing a website that is accessible to all user groups including people with disabilities such as blindness and low vision, deafness and hearing loss, learning disabilities, cognitive limitations, limited movement, speech disabilities, photosensitivity and combinations of these.

Sinclair has designed the Site with accessibility in mind, following the guidelines laid down by the W3C Web Accessibility Initiative (WAI).

Web Content Accessibility Guidelines (WCAG) 2.0 covers a wide range of recommendations for making web content more accessible to a wider range of people with disabilities and will also often make web content more usable to users in general.

The 12 accessibility guidelines are:

  • Provide text alternatives for non-text content.
  • Provide captions and alternatives for audio and video content.
  • Make content adaptable; and make it available to assistive technologies.
  • Use sufficient contrast to make things easy to see and hear.
  • Make all functionality keyboard accessible.
  • Give users enough time to read and use content.
  • Do not use content that causes seizures.
  • Help users navigate and find content.
  • Make text readable and understandable.
  • Make content appear and operate in predictable ways.
  • Help users avoid and correct mistakes.
  • Maximize compatibility with current and future technologies.
  • There are three levels of conformance to the accessibility guidelines: A (lowest), AA, and AAA (highest) and our aim is to conform to AA Level. However these are guidelines only and in some instances it is not practical to conform exactly to all checkpoints. If you have any queries about the accessibility of this website please contact [email protected]

Indication

Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

Important Safety Considerations

The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal...

Indication

Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

Important Safety Considerations

The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

To report a side effect with Silhouette InstaLift, please send the details to [email protected]. Click here for complete Instructions For Use.

The Silhouette InstaLift device is available only through a licensed practitioner.

REFERENCE

Few JW, Vachon G, Pintas S, Smith JR. Nonsurgical tissue repositioning: analysis of long-term results and patient satisfaction from 100 absorbable suture suspension cases. Aesthet Surg J Open Forum. 2019;2(1):